American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

McKesson Corporation

MCK Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

MCK historical prices

$MCK stock is featured in our Rob Bresnahan, Sector Weighted DC Insider, and Transportation and Infra. Committee (House) strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of MCK by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 10, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 20, 2026
Rick Larsen House / D Purchase $1,001 - $15,000 Jul 08, 2026
Jonathan L. Jackson House / D Sale $1,001 - $15,000 Jun 15, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Jun 02, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 May 27, 2026
Ro Khanna House / D Sale $15,001 - $50,000 May 15, 2026
Ro Khanna House / D Sale $1,001 - $15,000 May 01, 2026
Lizzie Fletcher House / D Sale $1,001 - $15,000 Apr 08, 2026
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 27, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Mar 23, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 24, 2026
Markwayne Mullin Senate / R Purchase $15,001 - $50,000 Feb 04, 2026
Markwayne Mullin Senate / R Purchase $15,001 - $50,000 Jan 05, 2026
Markwayne Mullin Senate / R Purchase $15,001 - $50,000 Jan 05, 2026
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Dec 19, 2025
Jared Moskowitz House / D Purchase $1,001 - $15,000 Dec 02, 2025
Jared Moskowitz House / D Purchase $1,001 - $15,000 Dec 02, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Nov 18, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 03, 2025
Jared Moskowitz House / D Purchase $1,001 - $15,000 Oct 10, 2025
Jonathan L. Jackson House / D Sale $1,001 - $15,000 Oct 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 29, 2025
Val T. Hoyle House / D Sale $1,001 - $15,000 Sep 23, 2025
Val T. Hoyle House / D Purchase $1,001 - $15,000 Sep 10, 2025
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Aug 05, 2025
Ritchie Torres House / D Sale $1,001 - $15,000 Jul 11, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 12, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Apr 29, 2025
Jonathan L. Jackson House / D Purchase $1,001 - $15,000 Apr 23, 2025
Josh Gottheimer House / D Sale $1,001 - $15,000 Apr 09, 2025
Jonathan L. Jackson House / D Purchase $1,001 - $15,000 Mar 24, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 06, 2025
Jonathan L. Jackson House / D Purchase $1,001 - $15,000 Mar 04, 2025
Jonathan L. Jackson House / D Purchase $1,001 - $15,000 Mar 03, 2025
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Jan 24, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jan 17, 2025
Jared Moskowitz House / D Purchase $1,001 - $15,000 Jan 15, 2025
Jared Moskowitz House / D Purchase $1,001 - $15,000 Jan 15, 2025
Julia Letlow House / R Purchase $1,001 - $15,000 Dec 18, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 14, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Oct 11, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Byron Donalds House / R Purchase $1,001 - $15,000 Oct 01, 2024
Byron Donalds House / R Purchase $1,001 - $15,000 Oct 01, 2024
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep 12, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 02, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 02, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Jul 02, 2024
MCK Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MCK Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MCK Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in MCK holdings by institutional investors

Insider Trading

Quarterly net insider trading by MCK's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $530,000 Jul 20, 2026 Issue: Manufacturing Health Issues Medicare/Medicaid Pharmacy
  • $860,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Pharmacy Manufacturing
  • $1,180,000 Jan 19, 2026 Issue: Health Issues Medicare/Medicaid Pharmacy Manufacturing
  • $530,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Pharmacy Manufacturing
  • $460,000 Jul 17, 2025 Issue: Health Issues Medicare/Medicaid Pharmacy Manufacturing
  • $1,220,000 Apr 24, 2025 Issue: Pharmacy Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $560,000 Jan 21, 2025 Issue: Pharmacy Taxation/Internal Revenue Code Tariff (miscellaneous tariff bills) Health Issues Medicare/Medicaid
  • $640,000 Oct 17, 2024 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $650,000 Jul 19, 2024 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $720,000 Jan 20, 2024 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $530,000 Oct 20, 2023 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $1,230,000 Aug 09, 2023 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $810,000 Aug 09, 2023 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $510,000 Jul 20, 2023 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $440,000 Oct 20, 2022 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $340,000 Jul 20, 2022 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $890,000 Apr 20, 2022 Issue: Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $520,000 Jan 20, 2022 Issue: None
  • $520,000 Oct 20, 2021 Issue: None
  • $540,000 Jul 20, 2021 Issue: None
  • $530,000 Apr 20, 2021 Issue: None
  • $340,000 Jan 20, 2021 Issue: None
  • $230,000 Nov 24, 2020 Issue: None
  • $200,000 Jul 20, 2020 Issue: None
  • $515,000 Apr 20, 2020 Issue: None
  • $710,000 Jan 21, 2020 Issue: None
  • $430,000 Oct 21, 2019 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Tariff (miscellaneous tariff bills)
  • $340,000 Jul 22, 2019 Issue: Pharmacy Medicare/Medicaid Health Issues Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code
  • $670,000 Apr 22, 2019 Issue: Pharmacy Medicare/Medicaid Health Issues Tariff (miscellaneous tariff bills) Taxation/Internal Revenue Code
  • $210,000 Jan 22, 2019 Issue: Tariff (miscellaneous tariff bills) Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $210,000 Oct 22, 2018 Issue: Tariff (miscellaneous tariff bills) Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $270,000 Jul 20, 2018 Issue: Tariff (miscellaneous tariff bills) Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $680,000 Apr 20, 2018 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $315,000 Jan 22, 2018 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $200,000 Oct 20, 2017 Issue: Medicare/Medicaid Health Issues Pharmacy Taxation/Internal Revenue Code
  • $212,000 Jul 20, 2017 Issue: Medicare/Medicaid Veterans Health Issues Pharmacy Taxation/Internal Revenue Code
  • $570,000 Apr 20, 2017 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $340,000 Jan 23, 2017 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $220,000 Oct 20, 2016 Issue: Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Pharmacy
  • $220,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Veterans Taxation/Internal Revenue Code Pharmacy
  • $515,000 Apr 20, 2016 Issue: Pharmacy Medicare/Medicaid Health Issues Veterans Taxation/Internal Revenue Code
  • $335,000 Jan 20, 2016 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $202,000 Oct 20, 2015 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $220,000 Jul 20, 2015 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $572,000 Apr 20, 2015 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $338,000 Jan 20, 2015 Issue: Pharmacy Medicare/Medicaid Health Issues Veterans Taxation/Internal Revenue Code
  • $240,000 Oct 20, 2014 Issue: Medicare/Medicaid Veterans Health Issues Pharmacy Taxation/Internal Revenue Code
  • $250,000 Aug 01, 2014 Issue: Medicare/Medicaid Health Issues Pharmacy Taxation/Internal Revenue Code Veterans
  • $425,000 Apr 21, 2014 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $560,000 Jan 21, 2014 Issue: Medicare/Medicaid Veterans Health Issues Pharmacy Taxation/Internal Revenue Code
  • $290,000 Oct 21, 2013 Issue: Medicare/Medicaid Veterans Health Issues Pharmacy Taxation/Internal Revenue Code
  • $330,000 Jul 22, 2013 Issue: Pharmacy Veterans Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $520,000 Apr 22, 2013 Issue: Pharmacy Health Issues Medicare/Medicaid Veterans Taxation/Internal Revenue Code
  • $600,000 Jan 22, 2013 Issue: Medicare/Medicaid Health Issues Veterans Taxation/Internal Revenue Code Pharmacy
  • $300,000 Oct 22, 2012 Issue: Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Pharmacy
  • $380,000 Jul 20, 2012 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $748,977 Apr 20, 2012 Issue: Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Pharmacy
  • $630,000 Jan 20, 2012 Issue: Veterans Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $340,000 Oct 20, 2011 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $470,000 Jul 20, 2011 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $680,000 Apr 20, 2011 Issue: Health Issues Pharmacy Veterans Medicare/Medicaid Taxation/Internal Revenue Code
  • $280,000 Jan 20, 2011 Issue: Veterans Health Issues Medicare/Medicaid Pharmacy Taxation/Internal Revenue Code
  • $110,000 Oct 20, 2010 Issue: Health Issues Pharmacy Taxation/Internal Revenue Code Medicare/Medicaid Financial Institutions/Investments/Securities Veterans
  • $240,000 Jul 20, 2010 Issue: Pharmacy Health Issues Veterans Medicare/Medicaid Financial Institutions/Investments/Securities Taxation/Internal Revenue Code
  • $341,256 Apr 20, 2010 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $433,000 Apr 20, 2010 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $281,205 Oct 20, 2009 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $210,000 Jul 20, 2009 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $210,000 Apr 20, 2009 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $180,000 Jan 21, 2009 Issue: Pharmacy Medicare/Medicaid Health Issues Veterans Taxation/Internal Revenue Code Financial Institutions/Investments/Securities
  • $205,000 Oct 20, 2008 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Financial Institutions/Investments/Securities
  • $205,000 Jul 21, 2008 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $155,000 Apr 21, 2008 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Budget/Appropriations
  • $480,000 Feb 14, 2008 Issue: Pharmacy Budget/Appropriations Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $560,000 Aug 09, 2007 Issue: Pharmacy Budget/Appropriations Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code
  • $320,000 Feb 14, 2007 Issue: Pharmacy Budget/Appropriations Medicare/Medicaid Veterans Health Issues
  • $300,000 Aug 14, 2006 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy
  • $380,000 Feb 14, 2006 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy
  • $320,000 Aug 18, 2005 Issue: Pharmacy Health Issues Medicare/Medicaid Budget/Appropriations
  • $220,000 Feb 16, 2005 Issue: Medicare/Medicaid Budget/Appropriations Pharmacy Health Issues
  • $280,000 Aug 19, 2004 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy
  • $100,000 Feb 20, 2004 Issue: None
  • $100,000 Sep 08, 2003 Issue: Health Issues Medicare/Medicaid Pharmacy
  • $100,000 Feb 25, 2003 Issue: Health Issues Medicare/Medicaid Pharmacy
  • $100,000 Aug 26, 2002 Issue: Pharmacy Health Issues Medicare/Medicaid Budget/Appropriations
  • $40,000 Mar 11, 2002 Issue: Pharmacy Medicare/Medicaid Health Issues
  • $60,000 Aug 14, 2001 Issue: Medicare/Medicaid Pharmacy Health Issues Taxation/Internal Revenue Code Transportation
  • $40,000 Feb 14, 2001 Issue: Health Issues Medicare/Medicaid Pharmacy
  • $40,000 Aug 14, 2000 Issue: Health Issues Medicare/Medicaid Pharmacy
  • $20,000 Feb 22, 2000 Issue: Transportation Taxation/Internal Revenue Code Economics/Economic Development Health Issues Medicare/Medicaid Beverage Industry Pharmacy Medical/Disease Research/Clinical Labs
  • $40,000 Aug 16, 1999 Issue: Pharmacy Beverage Industry Medicare/Medicaid Health Issues Transportation Economics/Economic Development
Revolving Door

Former government officials who have lobbied for MCK

28 former government officials from 18 congressional offices at 8 lobbying firms have lobbied for MCK, most recently Jul 21, 2026.

  • John B. Shadegg
    Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg Formerly with John B. Shadegg · TODD STRATEGY GROUP · Jul 21, 2026
  • Daniel Todd Senate Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid Formerly Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Ad · TODD STRATEGY GROUP · Jul 21, 2026
  • Lee Terry
    Nicolas Magallanes House Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander Formerly with Lee Terry · TODD STRATEGY GROUP · Jul 21, 2026
  • James C. Greenwood
    Joel White House New Staff Director, Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays Formerly with James C. Greenwood · MONUMENT ADVOCACY · Feb 13, 2026
  • Jean Schmidt
    Jennifer Steger House New Scheduler/Legislative Assistant, Rep. Jean Schmidt; Executive Assistant/Legislative Assistant, Rep. Jim Gerlach Formerly with Jean Schmidt · MONUMENT ADVOCACY · Feb 13, 2026
  • Michael C. Burgess
    Taylor Sexton House Advisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess Formerly with Michael C. Burgess · TODD STRATEGY GROUP · Jan 21, 2026
  • Christopher Shays
    Joel White House Former Staff Director, House Ways & Means Health Subcommittee; L.A. for Rep. Chris Shays Formerly with Christopher Shays · HORIZON GOVERNMENT AFFAIRS · Jan 16, 2026
  • Jean Schmidt
    Jennifer Steger House Scheduler/Legislative Assistant, Rep. Jean Schmidt; Executive Assistant/Legislative Assistant, Rep. Jim Gerlach Formerly with Jean Schmidt · HORIZON GOVERNMENT AFFAIRS · Jan 16, 2026
See all 28 on the Revolving Door dashboard
Corporate Lobbying

MCK Estimated quarterly lobbying spending

Revenue Breakdown

MCK Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
MCK Income Statement
MCK Balance Sheet
MCK Cash Flow
U.S. Patents

New MCK patent grants

  • Patent Title: Apparatuses and systems for the automated retrieval, transport, and processing of articles Aug. 18, 2026
  • Patent Title: Method, apparatus, and computer program product for using machine learning to generate an offset amount Aug. 11, 2026
  • Patent Title: Advanced prediction of shipping attributes of a package in a dispensing pharmacy May. 19, 2026
  • Patent Title: Methods and systems for supply chain analytics using visualizations and standardization constructs May. 05, 2026
  • Patent Title: Systems and methods for determining and communicating patient incentive information to a prescriber Feb. 10, 2026
  • Patent Title: Method, apparatus, and computer program product for utilizing accumulation records to reduce network transactions Feb. 10, 2026
  • Patent Title: Method, apparatus, and computer program product for providing real-time pricing information Jan. 13, 2026
  • Patent Title: Method, apparatus, and computer program product for estimating a target quantitative measure based upon historical electronic messages Jan. 06, 2026
  • Patent Title: Method, apparatus, and computer program product for providing real-time pricing information Nov. 11, 2025
  • Patent Title: Computing device, method and computer program product for constructing a consolidated message Nov. 11, 2025
  • Patent Title: Risk-based vulnerability management Aug. 12, 2025
  • Patent Title: Method, apparatus, and computer program product for estimating a target quantitative measure based upon historical electronic messages Jul. 22, 2025
  • Patent Title: Systems and methods for automated prescription preparation Jul. 22, 2025
  • Patent Title: Systems and methods for class of trade recommendations for a healthcare site Jul. 08, 2025
  • Patent Title: Methods and systems for converting unstructured data into an encoded, structured representation Jun. 24, 2025
  • Patent Title: Method, apparatus, and computer program product for generating summary data objects Jun. 10, 2025
  • Patent Title: Computing system and method for supporting selective prioritization May. 27, 2025
  • Patent Title: Verification bypass in a dispensing pharmacy Mar. 18, 2025
  • Patent Title: Programmable hardware proxy for assessment of control logic Mar. 04, 2025
  • Patent Title: Method, apparatus, and computer program product for partitioning prescription transaction costs in an electronic prescription transaction Feb. 18, 2025
  • Patent Title: Method, apparatus, and computer program product for reformatting an electronic prescription transaction Feb. 18, 2025
  • Patent Title: Method, apparatus, and computer program product for generating alternative evaluation messages Jan. 14, 2025
  • Patent Title: Methods and systems for association rule mining Jan. 07, 2025
  • Patent Title: Systems and methods for automated prescription preparation Dec. 31, 2024
  • Patent Title: Alternative therapy identification system Dec. 10, 2024
  • Patent Title: Method, apparatus and computer program product for constructing an updated order and verifying compliance with predefined rule(s) Nov. 26, 2024
  • Patent Title: Methods and systems for device maintenance Nov. 26, 2024
  • Patent Title: Apparatuses and systems for the automated retrieval and transport of articles Nov. 19, 2024
  • Patent Title: Methods, systems, and apparatuses for storage analysis and management Sep. 10, 2024
  • Patent Title: Adherence monitoring and notification system Jun. 25, 2024
  • Patent Title: Methods, systems, and apparatuses for improved quality assurance Jun. 18, 2024
  • Patent Title: Method, apparatus, and computer program product for utilizing accumulation records to reduce network transactions Apr. 23, 2024
  • Patent Title: Systems and methods for automated prescription preparation Apr. 23, 2024
  • Patent Title: Methods and systems for supply chain analytics Apr. 16, 2024
  • Patent Title: Method, apparatus, and computer program product for constructing an updated order including information from different sources Sep. 12, 2023
  • Patent Title: Method, apparatus and computer program product for conducting a multi-stage verification Sep. 12, 2023
  • Patent Title: Method, apparatus, and computer program product for replenishment of articles in a dispensing system Oct. 03, 2017
  • Patent Title: Enterprise management system Oct. 03, 2017
  • Patent Title: Providing user-defined messages Sep. 26, 2017
  • Patent Title: Systems and methods for a healthcare network survey solution Aug. 15, 2017
  • Patent Title: Apparatus for providing a tablet case for touch-sensitive devices Feb. 28, 2017
  • Patent Title: Data validation Oct. 04, 2016
  • Patent Title: Method for facilitating cooperative interaction between software applications May. 17, 2016
  • Patent Title: Enterprise management system Feb. 23, 2016
  • Patent Title: Data export/import from multiple data sources to a destination data repository using corresponding data exporters and an importer Jul. 01, 2014
  • Patent Title: Pharmaceutical package having a twistable actuator and associated method of accessing medication Mar. 04, 2014
  • Patent Title: Methods and systems to transmit, view, and manipulate medical images in a general purpose viewing agent Feb. 18, 2014
  • Patent Title: Methods, computer program products, apparatuses, and systems for facilitating viewing and manipulation of an image on a client device Aug. 27, 2013
  • Patent Title: Closed loop medication use system and method Jul. 02, 2013
  • Patent Title: Pharmaceutical dust extraction system and method Apr. 02, 2013
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to MCK from public contracts

MCK News

Recent insights relating to MCK

CNBC Recommendations

Recent picks made for MCK stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MCK

MCK Analyst Ratings

MCK Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MCK Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MCK stock a Buy, Sell, or Hold?

  • What is the price target for $MCK stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MCK Top Shareholders
Shareholder
Shares Held
MCK Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MCK stock?

  • Who owns the most shares of $MCK stock?

  • What funds own $MCK stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MCK Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MCK Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MCK

McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

  • Address Irving, TX
  • Market Cap 103.9 billion
  • Employees 43,000
  • Industrial Classification Wholesale-Drugs, Proprietaries & Druggists' Sundries

McKesson Corporation (MCK) Historical Stock Prices

McKesson Corporation (MCK) closed at $891.23 on September 22, 2026. Over the past year its adjusted close ranged from $694.26 to $993.55. Daily prices go back to January 2, 2014, 3,199 trading days in all.

  • 1 month+3.87%
  • 3 months+16.79%
  • Year to date+8.97%
  • 1 year+28.37%
  • 3 years+105.87%
  • 5 years+351.22%
  • Max+509.50%
See every congressional and insider trade on the MCK price chart

Quiver Premium charts MCK's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 891.11 897.57 882.88 891.23 891.23 935,680
Sep 21, 2026 874.79 895.34 873.35 886.47 886.47 940,313
Sep 18, 2026 872.78 881.05 864.12 874.65 874.65 2,707,475
Sep 17, 2026 886.11 889.81 874.73 879.57 879.57 577,256
Sep 16, 2026 895.57 897.68 887.29 887.29 887.29 902,279
Sep 15, 2026 902.31 907.50 883.59 899.56 899.56 1,151,062
Sep 14, 2026 900.00 912.00 893.38 910.95 910.95 619,297
Sep 11, 2026 888.37 893.92 874.31 881.51 881.51 888,805
Sep 10, 2026 899.77 904.83 879.24 880.86 880.86 852,973
Sep 9, 2026 889.25 897.51 880.27 891.68 891.68 972,384
Sep 8, 2026 891.45 904.50 877.53 889.12 889.12 747,849
Sep 4, 2026 911.15 921.09 905.10 907.99 907.99 879,268
Sep 3, 2026 924.89 929.95 916.14 921.38 921.38 816,793
Sep 2, 2026 914.29 928.49 910.65 924.78 924.78 856,563
Sep 1, 2026$0.94 dividend 887.70 914.43 886.83 906.77 906.77 787,987
Aug 31, 2026 882.83 892.80 876.48 885.32 884.40 1,382,718
Aug 28, 2026 895.04 900.22 890.79 893.39 892.47 606,054
Aug 27, 2026 889.27 891.95 880.77 890.51 889.59 1,108,251
Aug 26, 2026 905.54 918.00 891.99 896.65 895.72 1,059,205
Aug 25, 2026 871.40 905.66 869.37 905.09 904.15 882,581
Aug 24, 2026 861.47 875.64 859.75 873.79 872.88 600,502
Aug 21, 2026 839.84 867.91 837.88 858.90 858.01 1,580,737
Aug 20, 2026 850.00 858.68 838.71 838.75 837.88 557,686
Aug 19, 2026 864.22 869.99 850.01 853.71 852.83 938,781
Aug 18, 2026 870.23 886.14 867.65 869.26 868.36 618,721
Aug 17, 2026 859.49 879.34 855.93 859.92 859.03 1,137,251
Aug 14, 2026 859.74 869.79 852.99 869.00 868.10 614,390
Aug 13, 2026 873.09 875.46 856.69 856.69 855.80 992,495
Aug 12, 2026 901.90 901.98 873.35 878.73 877.82 1,096,071
Aug 11, 2026 877.33 902.05 877.33 901.77 900.84 805,018
Aug 10, 2026 873.04 894.74 870.47 879.87 878.96 809,857
Aug 7, 2026 864.34 889.69 864.32 869.58 868.68 1,562,208
Aug 6, 2026 912.19 912.50 840.00 871.38 870.48 1,607,598
Aug 5, 2026 840.40 879.48 840.40 877.23 876.32 1,143,323
Aug 4, 2026 815.99 835.95 810.88 830.43 829.57 1,089,482
Aug 3, 2026 858.55 863.08 822.65 827.14 826.28 1,439,922
Jul 31, 2026 850.00 863.55 843.72 856.19 855.30 773,568
Jul 30, 2026 868.68 877.15 862.66 865.51 864.61 990,058
Jul 29, 2026 900.00 907.00 887.61 888.56 887.64 838,010
Jul 28, 2026 868.82 894.10 865.50 889.50 888.58 1,602,028
Jul 27, 2026 841.87 856.52 836.86 850.06 849.18 799,752
Jul 24, 2026 829.93 843.53 827.48 840.90 840.03 823,784
Jul 23, 2026 811.46 825.02 809.94 824.49 823.64 755,411
Jul 22, 2026 834.13 840.00 808.56 814.04 813.20 710,500
Jul 21, 2026 824.56 830.93 820.50 828.84 827.98 846,485
Jul 20, 2026 835.74 839.30 825.16 831.46 830.60 698,171
Jul 17, 2026 852.81 861.00 839.91 841.39 840.52 1,118,657
Jul 16, 2026 808.30 843.80 804.12 841.31 840.44 1,329,425
Jul 15, 2026 799.90 811.38 793.60 796.35 795.52 664,847
Jul 14, 2026 802.01 812.91 790.57 803.37 802.54 1,115,812
Jul 13, 2026 812.87 822.38 806.24 812.28 811.44 618,710
Jul 10, 2026 793.22 806.49 791.18 805.96 805.12 491,756
Jul 9, 2026 812.09 817.80 786.81 792.81 791.99 1,005,213
Jul 8, 2026 807.85 823.86 803.39 818.66 817.81 1,125,389
Jul 7, 2026 793.56 811.91 792.50 807.33 806.49 1,109,897
Jul 6, 2026 784.72 789.10 776.00 784.23 783.42 1,130,744
Jul 2, 2026 770.00 787.36 770.00 786.30 785.49 952,677
Jul 1, 2026 757.00 772.51 747.65 768.06 767.26 1,200,758
Jun 30, 2026 746.02 760.70 744.58 755.60 754.82 1,688,517
Jun 29, 2026 771.63 781.71 745.64 747.53 746.76 1,559,898
Jun 26, 2026 777.48 784.14 761.16 763.51 762.72 1,736,310
Jun 25, 2026 766.56 782.68 762.96 763.81 763.02 1,186,746
Jun 24, 2026 768.23 777.80 762.45 766.55 765.76 1,279,377
Jun 23, 2026 762.76 768.76 754.49 763.91 763.12 1,363,683
Jun 22, 2026 751.70 757.18 744.45 744.85 744.08 1,454,600
Jun 18, 2026 775.72 778.01 747.40 750.63 749.85 2,477,060
Jun 17, 2026 775.13 784.67 772.00 779.80 778.99 1,078,966
Jun 16, 2026 783.06 787.57 771.29 785.43 784.62 659,199
Jun 15, 2026 778.88 781.81 762.54 779.78 778.97 824,637
Jun 12, 2026 790.71 796.54 782.47 784.05 783.24 608,939
Jun 11, 2026 792.63 800.36 787.01 787.19 786.38 827,213
Jun 10, 2026 788.00 794.00 780.66 790.44 789.62 637,619
Jun 9, 2026 763.00 787.26 759.25 784.23 783.42 882,386
Jun 8, 2026 763.11 782.75 761.99 766.64 765.85 794,813
Jun 5, 2026 764.00 781.27 759.85 775.66 774.86 982,121
Jun 4, 2026 751.56 759.09 747.50 756.95 756.17 902,693
Jun 3, 2026 740.17 743.28 729.19 739.53 738.76 786,372
Jun 2, 2026 735.27 738.97 730.15 736.78 736.02 885,434
Jun 1, 2026$0.82 dividend 735.50 743.00 730.66 734.82 734.06 913,681
May 29, 2026 760.04 761.99 738.09 742.44 740.84 1,938,630
May 28, 2026 754.68 767.51 753.62 756.98 755.35 1,450,034
May 27, 2026 754.37 763.78 750.35 756.47 754.84 1,367,287
May 26, 2026 760.01 766.66 750.49 754.40 752.78 1,978,183
May 22, 2026 769.14 772.94 759.30 766.08 764.43 2,323,957
May 21, 2026 752.57 766.61 748.97 766.50 764.85 1,640,876
May 20, 2026 761.23 765.51 751.48 754.68 753.06 1,088,738
May 19, 2026 780.00 782.48 761.89 761.89 760.25 1,264,563
May 18, 2026 757.25 777.35 756.24 775.97 774.30 1,199,553
May 15, 2026 754.06 766.43 751.63 760.57 758.93 1,534,439
May 14, 2026 736.52 750.75 736.07 747.23 745.62 933,576
May 13, 2026 727.69 748.62 727.69 737.18 735.60 966,010
May 12, 2026 731.45 742.30 724.70 734.69 733.11 951,694
May 11, 2026 743.45 755.00 723.68 725.17 723.61 1,693,267
May 8, 2026 739.75 772.42 726.02 736.09 734.51 2,179,559
May 7, 2026 739.90 755.85 729.68 754.76 753.14 2,020,750
May 6, 2026 777.00 777.00 735.79 743.67 742.07 2,877,160
May 5, 2026 809.51 811.96 800.30 801.01 799.29 882,286
May 4, 2026 808.30 813.37 800.36 807.85 806.11 839,112
May 1, 2026 820.25 821.00 807.58 814.02 812.27 633,826
Apr 30, 2026 818.22 822.21 791.09 815.20 813.45 1,367,646
Apr 29, 2026 829.64 834.57 822.00 822.63 820.86 791,286
Apr 28, 2026 836.33 841.85 829.66 835.00 833.21 813,256
Apr 27, 2026 827.01 835.19 822.54 828.32 826.54 934,880
Apr 24, 2026 829.00 830.52 817.44 828.11 826.33 692,330
Apr 23, 2026 827.51 836.85 825.77 836.10 834.30 673,901
Apr 22, 2026 840.77 847.05 821.99 829.23 827.45 1,117,989
Apr 21, 2026 858.00 858.00 836.62 842.25 840.44 1,241,001
Apr 20, 2026 864.99 873.03 853.43 859.04 857.19 582,299
Apr 17, 2026 866.97 867.83 855.50 866.38 864.52 833,202
Apr 16, 2026 863.74 871.18 861.01 867.34 865.48 520,746
Apr 15, 2026 861.84 869.97 857.84 863.42 861.56 465,639
Apr 14, 2026 862.85 875.53 857.86 862.79 860.94 614,421
Apr 13, 2026 865.47 870.71 855.18 864.57 862.71 554,752
Apr 10, 2026 869.74 873.20 855.11 865.60 863.74 615,265
Apr 9, 2026 869.01 879.10 868.02 873.43 871.55 593,241
Apr 8, 2026 859.29 873.83 850.59 871.18 869.31 875,724
Apr 7, 2026 857.81 866.00 845.52 856.62 854.78 892,153
Apr 6, 2026 862.15 877.77 850.84 856.77 854.93 803,716
Apr 2, 2026 872.17 887.25 866.79 884.28 882.38 570,800
Apr 1, 2026 863.08 880.86 863.00 872.32 870.45 729,561
Mar 31, 2026 866.71 866.71 846.73 865.36 863.50 898,972
Mar 30, 2026 869.95 875.07 856.43 860.19 858.34 689,205
Mar 27, 2026 862.52 864.89 852.55 860.16 858.31 840,958
Mar 26, 2026 879.62 884.07 863.05 863.56 861.70 835,226
Mar 25, 2026 881.33 892.22 877.03 879.75 877.86 669,463
Mar 24, 2026 876.08 887.17 864.78 881.94 880.04 697,218
Mar 23, 2026 896.17 904.43 876.74 877.01 875.12 660,310
Mar 20, 2026 893.48 903.96 875.97 885.84 883.94 1,937,124
Mar 19, 2026 922.67 934.17 898.07 898.95 897.02 899,301
Mar 18, 2026 938.94 944.42 916.61 920.35 918.37 767,412
Mar 17, 2026 942.91 948.63 923.95 941.89 939.87 755,754
Mar 16, 2026 947.34 953.68 936.05 943.25 941.22 612,402
Mar 13, 2026 950.35 959.95 937.34 940.91 938.89 543,267
Mar 12, 2026 931.26 949.86 928.00 944.36 942.33 522,988
Mar 11, 2026 921.15 940.43 917.97 934.29 932.28 478,185
Mar 10, 2026 944.23 945.00 925.09 928.69 926.69 645,638
Mar 9, 2026 920.11 942.17 913.09 942.16 940.13 765,801
Mar 6, 2026 927.84 928.43 909.77 919.26 917.28 921,523
Mar 5, 2026 948.10 948.38 920.04 931.35 929.35 1,479,611
Mar 4, 2026 991.29 992.65 977.32 978.71 976.61 550,883
Mar 3, 2026 989.05 999.00 973.00 995.69 993.55 571,756
Mar 2, 2026$0.82 dividend 990.00 995.07 979.80 990.95 988.82 523,060
Feb 27, 2026 977.28 987.37 974.00 987.37 984.43 1,059,689
Feb 26, 2026 968.20 977.27 961.00 974.45 971.55 599,963
Feb 25, 2026 959.85 965.46 953.00 963.24 960.38 657,560
Feb 24, 2026 952.71 959.42 943.69 957.36 954.51 495,067
Feb 23, 2026 945.00 963.00 943.68 949.25 946.43 545,250
Feb 20, 2026 937.14 949.91 931.00 947.48 944.66 821,961
Feb 19, 2026 948.32 950.76 932.14 937.14 934.35 651,238
Feb 18, 2026 947.43 950.42 935.00 946.97 944.15 522,466
Feb 17, 2026 942.20 950.00 935.66 946.47 943.65 551,598
Feb 13, 2026 917.41 938.03 915.08 934.75 931.97 873,997
Feb 12, 2026 953.32 968.61 894.59 916.00 913.28 1,548,113
Feb 11, 2026 933.39 953.56 930.34 953.19 950.36 833,374
Feb 10, 2026 965.00 966.05 931.42 935.21 932.43 869,617
Feb 9, 2026 950.00 967.11 939.53 962.32 959.46 785,364
Feb 6, 2026 955.00 971.93 935.65 948.68 945.86 1,190,648
Feb 5, 2026 862.00 971.93 862.00 957.80 954.95 2,245,153
Feb 4, 2026 845.00 851.11 817.17 822.00 819.55 1,709,141
Feb 3, 2026 842.26 855.99 841.04 851.12 848.59 799,599
Feb 2, 2026 836.09 847.21 830.00 846.51 843.99 600,740
Jan 30, 2026 819.43 833.84 818.70 831.21 828.74 699,094
Jan 29, 2026 830.00 849.05 820.85 822.30 819.85 677,775
Jan 28, 2026 829.36 834.07 815.00 826.62 824.16 541,050
Jan 27, 2026 818.85 843.05 818.85 834.18 831.70 576,622
Jan 26, 2026 822.68 831.38 822.00 826.62 824.16 567,786
Jan 23, 2026 815.25 822.36 810.67 820.23 817.79 409,416
Jan 22, 2026 823.83 826.68 814.99 817.05 814.62 583,713
Jan 21, 2026 819.41 829.07 807.00 823.25 820.80 665,379
Jan 20, 2026 838.42 847.89 820.63 821.84 819.40 705,172
Jan 16, 2026 842.02 847.90 837.63 840.46 837.96 603,227
Jan 15, 2026 832.38 844.26 828.08 844.13 841.62 619,691
Jan 14, 2026 822.79 838.46 820.13 834.16 831.68 492,918
Jan 13, 2026 826.41 836.60 820.03 823.98 821.53 487,019
Jan 12, 2026 817.00 831.32 815.43 825.62 823.16 495,561
Jan 9, 2026 816.98 824.70 814.77 816.06 813.63 583,539
Jan 8, 2026 824.78 838.98 806.10 814.63 812.21 686,533
Jan 7, 2026 826.90 844.69 821.30 823.95 821.50 611,252
Jan 6, 2026 824.20 834.44 820.02 826.51 824.05 515,146
Jan 5, 2026 816.18 825.96 794.59 824.92 822.47 786,915
Jan 2, 2026 818.00 826.20 810.48 823.44 820.99 414,966
Dec 31, 2025 827.90 829.25 819.92 820.29 817.85 430,239
Dec 30, 2025 830.42 832.88 826.86 827.33 824.87 324,377
Dec 29, 2025 829.87 833.72 826.68 830.42 827.95 379,508
Dec 26, 2025 826.82 830.00 823.34 828.26 825.80 179,926
Dec 24, 2025 826.45 830.65 826.32 826.43 823.97 163,459
Dec 23, 2025 814.38 825.88 813.00 825.73 823.27 388,498
Dec 22, 2025 819.00 823.52 813.67 818.40 815.97 490,610
Dec 19, 2025 813.48 825.61 811.76 820.25 817.81 1,427,126
Dec 18, 2025 810.97 819.39 807.75 810.56 808.15 671,557
Dec 17, 2025 811.47 812.98 801.21 806.52 804.12 722,032
Dec 16, 2025 823.00 824.95 804.17 809.96 807.55 641,565
Dec 15, 2025 816.07 824.81 813.00 823.01 820.56 692,106
Dec 12, 2025 818.46 826.00 812.00 813.80 811.38 1,010,302
Dec 11, 2025 812.62 819.53 806.99 815.54 813.11 732,556
Dec 10, 2025 798.15 815.91 793.92 813.10 810.68 1,192,600
Dec 9, 2025 807.10 807.14 794.82 795.01 792.65 623,340
Dec 8, 2025 805.16 807.34 789.96 797.93 795.56 988,992
Dec 5, 2025 813.62 818.92 806.29 808.62 806.22 597,998
Dec 4, 2025 805.40 814.69 803.00 814.18 811.76 880,965
Dec 3, 2025 835.39 835.39 802.72 805.37 802.98 1,486,054
Dec 2, 2025 851.66 854.32 825.08 829.70 827.23 1,331,201
Dec 1, 2025$0.82 dividend 875.75 883.30 855.59 856.89 854.34 832,087
Nov 28, 2025 882.27 888.34 880.44 881.12 877.66 410,520
Nov 26, 2025 892.54 895.58 883.71 883.71 880.24 617,072
Nov 25, 2025 875.00 891.60 873.64 889.28 885.79 829,208
Nov 24, 2025 867.76 873.45 860.53 870.21 866.79 946,111
Nov 21, 2025 851.34 869.74 848.50 866.03 862.63 754,566
Nov 20, 2025 857.42 861.39 845.48 849.46 846.12 612,404
Nov 19, 2025 859.33 867.38 849.61 852.47 849.12 816,008
Nov 18, 2025 859.27 863.47 842.33 860.75 857.37 927,214
Nov 17, 2025 846.66 855.58 843.02 855.23 851.87 768,264
Nov 14, 2025 849.70 855.00 841.35 842.09 838.78 758,189
Nov 13, 2025 837.02 849.74 836.95 846.24 842.92 712,785
Nov 12, 2025 854.10 854.10 838.99 840.75 837.45 1,157,437
Nov 11, 2025 860.22 861.55 852.52 856.44 853.08 388,908
Nov 10, 2025 842.91 861.98 842.03 859.37 856.00 571,780
Nov 7, 2025 861.63 867.63 846.43 851.99 848.64 619,387
Nov 6, 2025 832.35 860.00 793.31 858.61 855.24 1,097,428
Nov 5, 2025 841.67 863.32 836.26 844.26 840.94 1,217,494
Nov 4, 2025 817.82 846.43 811.91 841.67 838.36 952,152
Nov 3, 2025 813.48 821.29 805.95 820.29 817.07 650,791
Oct 31, 2025 820.09 830.91 808.22 811.34 808.15 933,216
Oct 30, 2025 825.02 846.32 821.70 825.53 822.29 919,321
Oct 29, 2025 803.88 811.62 801.74 807.63 804.46 512,329
Oct 28, 2025 811.44 812.69 800.54 804.59 801.43 453,106
Oct 27, 2025 801.35 811.86 799.17 811.44 808.25 451,593
Oct 24, 2025 794.40 807.75 791.63 801.67 798.52 476,444
Oct 23, 2025 796.84 799.50 787.01 792.97 789.86 454,849
Oct 22, 2025 792.64 797.27 781.86 795.62 792.50 460,413
Oct 21, 2025 787.82 788.91 780.90 787.29 784.20 586,274
Oct 20, 2025 787.46 793.54 780.31 787.82 784.73 413,685
Oct 17, 2025 781.27 793.11 774.04 786.00 782.91 621,056
Oct 16, 2025 789.23 793.97 774.45 775.44 772.39 688,777
Oct 15, 2025 778.48 792.34 776.00 791.93 788.82 574,410
Oct 14, 2025 773.00 783.89 762.25 781.90 778.83 666,680
Oct 13, 2025 752.47 775.70 752.47 769.49 766.47 535,010
Oct 10, 2025 758.97 769.44 757.94 763.55 760.55 556,857
Oct 9, 2025 754.91 759.32 747.60 757.96 754.98 423,308
Oct 8, 2025 752.28 756.36 744.00 755.75 752.78 483,271
Oct 7, 2025 738.46 750.74 733.17 750.13 747.18 653,457
Oct 6, 2025 736.93 743.70 732.76 741.29 738.38 724,535
Oct 3, 2025 758.00 762.16 730.04 738.06 735.16 1,092,969
Oct 2, 2025 758.16 764.35 753.35 758.70 755.72 664,983
Oct 1, 2025 770.30 776.14 762.93 765.08 762.08 773,267
Sep 30, 2025 762.93 774.85 759.86 772.54 769.51 960,094
Sep 29, 2025 758.97 765.24 756.21 761.82 758.83 711,561
Sep 26, 2025 743.18 761.72 741.78 760.55 757.56 821,914
Sep 25, 2025 762.60 763.01 715.31 736.52 733.63 1,536,739
Sep 24, 2025 750.00 770.00 745.65 760.58 757.59 916,846
Sep 23, 2025 714.00 748.75 714.00 741.31 738.40 1,141,204
Sep 22, 2025 696.20 700.79 687.68 697.00 694.26 583,856

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
McKesson Corporation Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at MCK, per a recent SEC DEF 14A filing. We estimate that the median employee at MCKESSON CORP is paid $68,406.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation